{"version":"1.0","provider_name":"Cilcare","provider_url":"https:\/\/www.cilcare.com\/jp","title":"Mathieu Schu\u00e9 joins CILcare as Project Director of Drug Development and Translational Research - Cilcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"0MAt8eh8ci\"><a href=\"https:\/\/www.cilcare.com\/jp\/2021\/01\/14\/mathieu-schue-joins-cilcare\/\">Mathieu Schu\u00e9 joins CILcare as Project Director of Drug Development and Translational Research<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cilcare.com\/jp\/2021\/01\/14\/mathieu-schue-joins-cilcare\/embed\/#?secret=0MAt8eh8ci\" width=\"600\" height=\"338\" title=\"&#8220;Mathieu Schu\u00e9 joins CILcare as Project Director of Drug Development and Translational Research&#8221; &#8212; Cilcare\" data-secret=\"0MAt8eh8ci\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cilcare.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/01\/Mathieu-retouche-V2-1-1024x683.png","thumbnail_width":1024,"thumbnail_height":683,"description":"Montpellier, January 14th, 2021: CILcare, the world leading CRO specialized in the field of Hearing, recently had the immense pleasure of welcoming Dr. Mathieu Schu\u00e9 to the team as Project Director of Drug Development &amp; Translational Research. In this role, Mathieu Schu\u00e9 will dive into CILcare\u2019s preclinical models and read-outs, validate reference compounds for various hearing indications, and identify innovative development strategies to support preclinical to clinical drug translation and continuously improve CILcare\u2019s support to its clients and partners. With over 15 years of experience in the management of drug development projects, Mathieu Schu\u00e9 has successfully brought drug candidates from preclinical to clinical phases, especially in areas of unmet medical [&hellip;]"}